SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-003666
Filing Date
2019-06-27
Accepted
2019-06-27 16:51:54
Documents
1
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3861
  Complete submission text file 0001562180-19-003666.txt   5414
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences

Mailing Address 1700 KENT AVENUE WEST LAFAYETTE IN 46906
Business Address
Landis John B. (Reporting) CIK: 0001477283 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 19925983